Analysis of salbutamol enantiomers in human urine by chiral high-performance liquid chromatography and preliminary studies related to the stereoselective disposition kinetics in man.
Enantiomers of salbutamol, extracted from human urine, were successfully separated and quantitated by high-performance liquid chromatography with electrochemical detection. This direct resolution was accomplished using a chiral alpha 1-acid glycoprotein column (EnantioPac) maintained at 0 degrees C and a mobile phase consisting of a 0.1% (v/v) triethylamine in 5.3 mM citrate buffer, pH 7.2. An amperometric detector incorporating a glassy carbon electrode was employed for detection. The between-day coefficients of variation for the determination of R(-)- and S(+)-salbutamol in human urine were 4.1 and 4.7%, respectively, at a drug level of 1.0 microgram/ml. The urinary excretion ratio of the biologically active (-)-isomer to (+)-isomer in one healthy subject who received an intravenous dose of racemic salbutamol (1.0 mg) decreased continuously over a 12-h period. A similar excretion pattern exhibiting a far more extensive distortion in the enantiomeric ratio was found in three subjects dosed with a single 4-mg tablet of racemic salbutamol.
Department of Clinical Biochemistry, University of Toronto, Ontario, Canada.
Y K
YK
Tan
S J
SJ
Soldin
D000328:Adult; D000420:Albuterol / Q000493:pharmacokinetics / Q000652:urine*; D001192:Arylsulfatases; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D006868:Hydrolysis; D008297:Male; D013237:Stereoisomerism
D001192:Arylsulfatases; D000420:Albuterol